EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Pembrolizumab Failure in an Aggressive, Platinum-Resistant Primary Mediastinal Yolk Sac Tumor With Rapid Metastatic Dissemination, Spinal Cord Compression, and a Fatal Outcome

Salah Riyadh, Garred Cline

Cureus · 06.05.2026

DOI: 10.7759/cureus.108355 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 06.05.2026. Verfasst von Salah Riyadh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, University of Pikeville, Pikeville, USA. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

alpha-fetoproteinextragonadal germ cell tumorimmune checkpoint inhibitormetastatic progressionpembrolizumab resistanceplatinum resistanceprimary mediastinal yolk sac tumoryolk sac tumor

Autor:innen und Institutionen

  • Internal Medicine, University of Pikeville, Pikeville, USA.
  • Internal Medicine, Pikeville Medical Center, Pikeville, USA.

Zitieren

APA

Riyadh, S., & Cline, G. (2026). Pembrolizumab Failure in an Aggressive, Platinum-Resistant Primary Mediastinal Yolk Sac Tumor With Rapid Metastatic Dissemination, Spinal Cord Compression, and a Fatal Outcome. Cureus. https://doi.org/10.7759/cureus.108355

Vancouver

Riyadh S, Cline G. Pembrolizumab Failure in an Aggressive, Platinum-Resistant Primary Mediastinal Yolk Sac Tumor With Rapid Metastatic Dissemination, Spinal Cord Compression, and a Fatal Outcome. Cureus. 2026. doi:10.7759/cureus.108355

BibTeX
@article{Riyadh2026,
  author = {Riyadh, Salah and Cline, Garred},
  title = {Pembrolizumab Failure in an Aggressive, Platinum-Resistant Primary Mediastinal Yolk Sac Tumor With Rapid Metastatic Dissemination, Spinal Cord Compression, and a Fatal Outcome},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.108355}
}
Kostenlos starten →